Variant report
Variant | nsv526934 |
---|---|
Chromosome Location | chr6:117718303-117719528 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9401003 | chr6:117718303-117718304 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs371671682 | chr6:117718324-117718325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530282437 | chr6:117718357-117718358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529699255 | chr6:117718359-117718360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199816916 | chr6:117718360-117718361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549638309 | chr6:117718363-117718364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115638513 | chr6:117718387-117718388 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140813329 | chr6:117718388-117718389 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549978386 | chr6:117718406-117718407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571367875 | chr6:117718415-117718416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538749810 | chr6:117718420-117718421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369195730 | chr6:117718422-117718423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574271965 | chr6:117718454-117718455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554019697 | chr6:117718532-117718533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566054240 | chr6:117718536-117718537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536284028 | chr6:117718547-117718548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554824419 | chr6:117718550-117718551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539310573 | chr6:117718553-117718554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187639800 | chr6:117718601-117718602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543605283 | chr6:117718621-117718622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558792298 | chr6:117718629-117718630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192505705 | chr6:117718632-117718633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116777180 | chr6:117718639-117718640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559219738 | chr6:117718762-117718763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376403461 | chr6:117718810-117718811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3798387 | chr6:117718813-117718814 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs541483351 | chr6:117718916-117718917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561593104 | chr6:117718945-117718946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75086782 | chr6:117718948-117718949 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531892788 | chr6:117719015-117719016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549915112 | chr6:117719040-117719041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs3777973 | chr6:117719056-117719057 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs75680757 | chr6:117719110-117719111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547853613 | chr6:117719139-117719140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566067329 | chr6:117719146-117719147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536619083 | chr6:117719161-117719162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182383951 | chr6:117719226-117719227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578080331 | chr6:117719256-117719257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188024248 | chr6:117719261-117719262 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537342520 | chr6:117719365-117719366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34108003 | chr6:117719385-117719386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62430839 | chr6:117719396-117719397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577098049 | chr6:117719424-117719425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200457551 | chr6:117719444-117719445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148062936 | chr6:117719445-117719446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200254334 | chr6:117719447-117719448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs376530107 | chr6:117719452-117719453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76517505 | chr6:117719482-117719483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553006037 | chr6:117719491-117719492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9401004 | chr6:117719528-117719529 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Epilepsy | 22083797 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 17440070 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:117692600-117735800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr6:117716400-117719600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr6:117716600-117730600 | Weak transcription | HSMM | muscle |
4 | chr6:117717400-117718600 | Weak transcription | Left Ventricle | heart |
5 | chr6:117717800-117718800 | Weak transcription | HepG2 | liver |
6 | chr6:117718000-117718600 | Weak transcription | Liver | Liver |
7 | chr6:117718200-117728200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr6:117718600-117718800 | Enhancers | Liver | Liver |
9 | chr6:117718600-117718800 | Enhancers | Left Ventricle | heart |
10 | chr6:117718600-117719200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr6:117718800-117719200 | Enhancers | Fetal Brain Female | brain |
12 | chr6:117718800-117719200 | Enhancers | HepG2 | liver |
13 | chr6:117719000-117719200 | Enhancers | Osteobl | bone |
14 | chr6:117719200-117725800 | Weak transcription | Osteobl | bone |